{"product_id":"probicobacter-tablete","title":"Probicobacter tablete","description":"\u003cp\u003e\u003cspan\u003eProbicobacter tablete s \u003c\/span\u003e\u003cb\u003ePylopass\u003csup\u003eTM\u003c\/sup\u003e\u003c\/b\u003e\u003cspan\u003e, ki \u003c\/span\u003e\u003cb\u003ese veže s\u003cspan\u003e \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003ci\u003eHelicobacter pylori\u003c\/i\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003e \u003c\/span\u003ein prispeva k njenemu izločanju iz telesa\u003c\/b\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eZ dodatkom ekstrakta \u003c\/span\u003e\u003cb\u003ebrokolija\u003c\/b\u003e\u003cspan\u003e ter z\u003c\/span\u003e\u003cb\u003e\u003cspan\u003e \u003c\/span\u003evitamini A, C, B12\u003c\/b\u003e\u003cspan\u003e in\u003c\/span\u003e\u003cb\u003e\u003cspan\u003e \u003c\/span\u003ecinkom\u003c\/b\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003eKako se Probicobacter tablete s Pylopass\u003csup\u003eTM\u003c\/sup\u003e oprimejo \u003cem\u003eHelicobacter pylori\u003c\/em\u003e?\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003e\u003cspan\u003ePylopass\u003csup\u003eTM\u003c\/sup\u003e vsebuje površinske strukture z molekulami, ki prepoznajo in se oprimejo površine \u003cem\u003eHelicobacter pylori\u003c\/em\u003e.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\u003cspan\u003ePo vezavi se novo nastali ko-agregat (Pylopass\u003csup\u003eTM\u003c\/sup\u003e + \u003cem\u003eH. pylori\u003c\/em\u003e)  z odvajanjem blata izloči iz telesa. Pylopass\u003csup\u003eTM\u003c\/sup\u003e se veže specifično le s \u003cem\u003eH.pylori\u003c\/em\u003e in ne spremeni črevesne mikroflore.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eRezultati kliničnih študij Pylopass\u003csup\u003eTM\u003c\/sup\u003e:\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003e\u003cspan\u003ePo 14 dneh zmanjša obremenitev s \u003cem\u003eH. pylori\u003c\/em\u003e,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\u003cspan\u003ePrispeva k večji učinkovitosti anti- \u003cem\u003eH. pylori\u003c\/em\u003e terapije,\u003c\/span\u003e\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\u003cspan\u003ePrispeva k zmanjšanju simptomov nelagodja v želodcu.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003ePrednosti Probicobacter tablet Soria natural z Lactobacilus reuteri PylopassTM:\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003e\u003cspan\u003eStabilnost pri sobni temperaturi najmanj 2 leti. Shranjevanje v hladilniku ni potrebno.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\u003cspan\u003eDeluje specifično na H.pylori in ne vpliva na nobeno drugo bakterijo v črevesju.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\u003cspan\u003eStabilnost v kislem okolju želodca.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\u003cspan\u003eDobra toleranca, brez neželenih učinkov.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eViri:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e\u003cspan\u003eLactobacillus reuteri PylopassTM\u003c\/span\u003e\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e⦁ Mehling H, Busjahn A, Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass™) as a new approach to Helicobacter pylori control in humans. Nutrients. 2013 Aug 2;5 (8):3062-73. doi: 10.3390\/nu5083062.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e⦁ Holz C, Busjahn A, Mehling H, Arja S, Boettner M, Habibi H, Land C. Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study. ⦁ Probiotics Antimicrob Proteins. 2015 Jun; 7(2):91-100 doi: ⦁ 10.1007\/s12602-014-9181-3\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e⦁ Uspenskiy Yu.P, Fomin Yu. A, Ivanov S.V, Menaker I.O. Evolution in eradication therapy of HP -associated diseases: beyond the standards? Russian scientific publication in Gastroenterology No 17,2016\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e⦁ Parolova Ni, Komienko EA, Antonov PV, Egorov Mikhail Gorbunov EF, Dmitrienko MA. An innovative approach in the treatment of H. pylori infection in children.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e⦁ Pop Muresan IA, Liviu Pop L, Dumitrascu DL, Lactobacillus reuteri versus triple therapy for the eradication of Helicobacter pylori in functional dyspepsia. Gastroenterology. 2019. DOI: 10.15386\/mpr-1375.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e⦁ Buckley et al. The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: a placebo-controlled, single-blind study. BMC Nutrition (2018) 4:48 https:\/\/doi.org\/10.1186\/s40795-018-0257-4\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTong JL, ⦁ Ran ZH, ⦁ Shen J, ⦁ Zhang CX, ⦁ Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2007 Jan 15;25(2):155-68.\u003c\/span\u003e\u003c\/p\u003e\n","brand":"Soria Natural","offers":[{"title":"Default Title","offer_id":56633798590844,"sku":"20013","price":29.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/2162\/1884\/files\/probicobacter-somprimidos-soria-natural.jpg?v=1776165843","url":"https:\/\/soria-natural.si\/products\/probicobacter-tablete","provider":"Soria Natural","version":"1.0","type":"link"}